Southern Miss Fuels Biotech Growth in Mississippi
Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
- Latest
- Trending
Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
CyberArk Software sees 28% revenue growth and strong ARR boost, enhancing its leadership in identity security market.
RADCOM Limited records a 20% revenue increase for Q2 2024, with positive cash flow. Raises 2024 guidance amid robust 5G ...
Mayville Engineering sees 7% organic sales growth in Q2 2024, raises free cash flow guidance to $45M-$55M, and focuses on ...
Bridge Investment Group shows mixed results in Q2 2024 with a GAAP net loss but strong distributable earnings and strategic ...
Luminar Technologies restructures $422M debt, extends its maturity, and secures $100M non-dilutive capital, aiming for profitability by 2030.
Discover how PAHO and IDB are helping countries integrate AI into public health with their new readiness assessment toolkit.
Panda Biotech enters a 12-year PILOT agreement with Wichita Falls, paying reduced city taxes and utilizing city services.
"Discover 3 ways hybrid workforces benefit from a zero trust approach, ensuring data safety, better user experience, and simplified security ...
Rivian stock jumps 50% after Volkswagen's $5B investment in a joint venture to develop software tech for affordable and efficient ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.